Science 37 Inc is a clinical research company that uses technology to bring clinical trials directly to patients’ homes. Science 37 has developed a platform that makes it possible for patients to participate in clinical trials from anywhere in the world, using their smartphones and computers.

This not only allows patients to receive treatment for conditions they may not be able to access in their own country but also makes it possible for them to take part in clinical trials that they may not otherwise be able to participate in.

Science 37 is currently working with pharmaceutical companies, academic institutions, and contract research organizations (CROs) to conduct clinical trials for a variety of conditions.

Is Science 37 A Legitimate Organization?

Science 37 is a legitimate organization based in the United States, it is registered with the US Food and Drug Administration (FDA) as a clinical research organization, and have been accredited by the Better Business Bureau (BBB).

What Do Science 37 Do?

Science 37 provides a platform that allows patients to participate in clinical trials from anywhere in the world, using their own smartphones and computers.

More than just a physical and medical barrier, international borders can be an insurmountable obstacle for those who need treatment. However with the help of medication transported internationally or trials conducted locally many people have been able to receive their needed care without having themselves travel abroad which gives rise not only hope but also accessibility in regions where it may otherwise never reach due exclusively because there were no options available until now!

Here’s What We Know About Science 37

We have gone ahead and answered the most asked questions for you;

Who Founded Science 37?

Science 37 was founded in 2013 by Noah Craft & Belinda Tan.

How Many Employees Does Science 37 Have?

Science 37 has a team of more than 100 employees, including medical doctors, nurses, and other healthcare professionals.

Where is Science 37 Located?

The company is headquartered in Los Angeles, California, with offices in San Francisco and New York City.

When Did Science 37 Go Public?

Science 37 went public in October 2018, due to popular demand from patients and researchers who wanted to use the platform to conduct clinical trials.

How Much Funding Has Science 37 Received?

Science 37 have raised a total of $70 million in funding, from investors such as Google Ventures, Andreessen Horowitz, and Obvious Ventures, this was back in 2016, Now in 2019, they have partnered with Indeed to help them find employees as they plan to expand their services globally.

Who Is The Current CEO?

David Coman, who is also one of the co-founders, is the current CEO of Science 37.

David is a serial entrepreneur and has founded several companies in the healthcare space, including CareMessage, a non-profit that provides free health education to low-income patients, and Medable, a software company that helps pharmaceutical companies conduct clinical trials.

Why Is Science 37 Such A Good Idea?

The idea for Science 37 came about because the founders, Noah Craft and Belinda Tan, saw a need for a better way to conduct clinical trials.

They believed that the traditional model of clinical trials were outdated and that there was a better way to conduct them using technology.

This new model would not only be more efficient but would also be more accessible to patients, as they would not need to travel to a clinical trial site in order to receive treatment.

Science 37 has been able to successfully conduct clinical trials using this new model, and have even won awards for their innovation.

Science 37 not only gives more people access to clinical trials but they also make the process more efficient, which is a win-win for everyone involved, it can be so much quicker to set up and get results back from using Science 37 instead of waiting or trying to participate in a clinical trial the old-fashioned way.

What Types Of Trials Do Science 37 Provide?

The company has conducted clinical trials for a variety of conditions, including cancer, Alzheimer’s disease, and depression.

There have been many types of trials that Science 37 has conducted, including phase I, II, and III clinical trials.

Science 37 is constantly expanding the types of trials they offer, in order to provide more options for patients who are looking for treatment.

Conclusion

Science 37 offers other services such as patient recruitment, data management, and biostatistics.

They have a network of over 37,000 sites in 70 countries, which allows them to reach a large number of potential participants for their trials. Science 37 is dedicated to making clinical research more accessible and convenient for patients by making it possible to conduct trials remotely using mobile technology.

This allows patients to participate in trials from the comfort of their own homes instead of having to travel to a clinical site.

One can only imagine what the future holds when corporations like these mix technology with medicine in order to improve the quality of life and treatment people receive when they need it most and Science 37 is a prime example of this, making processes that once were very difficult to achieve, much easier by intuition.